A practice guide for continuous opioid therapy for refractory daily headache: patient selection, physician requirements, and treatment monitoring

Headache
Joel R SaperGretchen E Tietjen

Abstract

To provide a guide to the use and limitations of continuous opioid therapy (COT, or daily scheduled opioids) for refractory daily headache, based on the best available evidence and expert clinical experience. There has been a dramatic increase in opioid administration over the past 25 years, with limited evidence of efficacy for either pain reduction or increased function, and increasing evidence of adverse effects, including headache chronification. To date, there has been no consensus on headache-specific guidelines for selecting patients for COT, physician requirements, and treatment monitoring. A multidisciplinary committee of physicians and allied health professionals with extensive experience and expertise in the administration of opioids to headache patients, undertook a review of the available evidence from the research and clinical literature (using the PubMed database for articles through December 2009) to develop headache-specific treatment recommendations. This guide reflects the opinions of its authors and is not an official document of the American Headache Society. The guide identifies factors that would qualify or disqualify the use of COT, including, determination of intractability prior to initiating COT, requ...Continue Reading

References

Oct 1, 1991·Archives of Physical Medicine and Rehabilitation·A Jerome, R T Gross
Feb 1, 1990·Pain·R C TaitS Krause
Feb 1, 1995·British Journal of Anaesthesia·A CroninR Lydic
Jun 1, 1994·Accident; Analysis and Prevention·P SahdevT D Dogra
Oct 17, 1998·European Journal of Pediatrics·R BunikowskiM Obladen
Jul 31, 2001·Trends in Neurosciences·L R WatkinsS F Maier
Jun 28, 2002·Trends in Neurosciences·Frank PorrecaG F Gebhart
Dec 14, 2002·The Clinical Journal of Pain·Stanley L ChapmanBarbara A Reed
Aug 2, 2003·Clinical Pharmacology and Therapeutics·M Soledad CepedaBrian L Strom
Jan 31, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·David T CowanLaurie G Allan
May 26, 2004·Pain·Margaret A Caudill-SlosbergSteven Woloshin
Aug 20, 2004·Pharmacological Reviews·Irmgard Tegeder, Gerd Geisslinger
Sep 14, 2004·Journal of Neurobiology·Michael H OssipovFrank Porreca
Jan 14, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jennifer Y XieTodd W Vanderah
Mar 2, 2005·European Journal of Pain : EJP·Harald Breivik
Apr 20, 2005·Headache·Stafford ConwayJohn Rothrock
May 28, 2005·Anesthesia and Analgesia·Yan WangPamela Pierce Palmer
May 28, 2005·Anesthesia and Analgesia·Chante Buntin-MushockPamela Pierce Palmer
Jun 21, 2005·Pain·Tamara KingFrank Porreca
Oct 26, 2005·Trends in Neurosciences·Linda R WatkinsSteven F Maier
Dec 13, 2005·Arthritis and Rheumatism·J Denise PowerElizabeth M Badley
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Frédéric SimoninGuy Simonnet
Feb 28, 2006·Current Pain and Headache Reports·Jianren Mao
Feb 28, 2006·Current Pain and Headache Reports·Licia Grazzi, Frank Andrasik
Mar 2, 2006·Anesthesiology·Martin S Angst, J David Clark
Apr 19, 2006·The Journal of Pain : Official Journal of the American Pain Society·Yngvild OlsenDaniel E Ford
Apr 22, 2006·American Journal of Physical Medicine & Rehabilitation·Raul MarinWendy Miklos

❮ Previous
Next ❯

Citations

Dec 3, 2010·Current Treatment Options in Neurology·Frederick R Taylor, Robert G Kaniecki
Nov 15, 2012·Current Treatment Options in Neurology·Elliott Schulman, Brian E McGeeney
Aug 9, 2013·CNS Drugs·Joel R Saper, Arnaldo Neves Da Silva
Jul 26, 2012·Clinical Obstetrics and Gynecology·Christy F Pearce, Wendy F Hansen
Jun 2, 2015·Expert Opinion on Drug Metabolism & Toxicology·Anna FerrariEmilio Sternieri
Apr 12, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Lisa R WitkinMichael A Ashburn
Oct 17, 2012·Headache·Ronald J Kulich, Melissa Stone
Jan 9, 2013·Headache·Randolph W Evans
Jan 5, 2011·Headache·Randolph W Evans, Tad D Seifert
Jan 10, 2014·Headache·Egilius L H Spierings, R W Evans
Apr 5, 2014·Headache·Lawrence Robbins
Oct 17, 2013·Headache·Morris Levin
Apr 26, 2015·Disease-a-month : DM·Irene A Semenov
Jul 31, 2016·Current Pain and Headache Reports·Melissa T StoneRonald J Kulich
Aug 27, 2011·Journal of Applied Physiology·Harold J BellPhilippe Haouzi
May 26, 2020·The Journal of Headache and Pain·Alejandro Labastida-RamírezUNKNOWN European Headache Federation School of Advanced Studies (EHF-SAS)
Oct 9, 2020·The Journal of Pain : Official Journal of the American Pain Society·Yun ShenAmie J Goodin
Apr 28, 2011·Current Opinion in Supportive and Palliative Care

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Medicine
Alec B O'Connor, Robert H Dworkin
Annals of Internal Medicine
Roger ChouClinical Guidelines Committee of the American College of Physicians
Pain Medicine : the Official Journal of the American Academy of Pain Medicine
H WittinkD B Carr
International Journal of Radiation Oncology, Biology, Physics
Stephen LutzAmerican Society for Radiation Oncology (ASTRO)
© 2021 Meta ULC. All rights reserved